Bad cholesterol inhibits the breakdown of peripheral fat
[PRESS RELEASE, 20 November 2008] The so called bad cholesterol (LDL) inhibits the breakdown of fat in cells of peripheral deposits, according to a study from the Swedish medical university Karolinska Institutet. The discovery reveals a novel function of LDL as a regulator of fat turnover besides its well-established detrimental effects in promoting atherosclerosis. The study, which is a collaboration of two research groups at Karolinska Institutet, is published in the open-access journal PLoS ONE. It shows that LDL cholesterol slows the rate of fat breakdown (i.e. lipolysis) in adipocytes, the peripheral cells responsible for fat storage. Previously, it has been known that release of free fatty acid from the peripheral fat to the blood stream increases the synthesis of LDL precursors in the liver.
"The results of our study provide evidence of a reciprocal link between the liver and peripheral fat regulating fat turnover", says study-initiator Dr Johan Björkegren.
The discovery also opens up for new theories for the well-established association between blood lipids and the metabolic syndrome.
"If proven of general physiological importance, therapies lowering LDL, as for instances Statins, may also affect the turnover of peripheral fat," continues Dr Björkegren.
The study and has been performed on cell cultures and tissues from humans as well as mouse models with different levels of LDL. The inhibitory effect was also shown to be dependent on LDL receptors on the surface of the fat cells.
"The exact intracellular mechanism for how the binding of LDL to the surface of the fat cells inhibits the breakdown of intracellular fat remains to be revealed", say project leader Dr Josefin Skogsberg
Source: Karolinska Institutet
Related
- Cholesterol necessary for brain developmentFri, 2 Oct 2009, 9:16:30 EDT
- Novel mechanisms controlling insulin release and fat deposition discoveredTue, 13 May 2008, 10:28:37 EDT
- Scientists identify cholesterol-regulating genesTue, 7 Jul 2009, 13:44:33 EDT
- Inhibiting cholesterol-associated protein reduces high-risk blockages in arteriesMon, 22 Sep 2008, 16:08:58 EDT
- Cholesterol-reducing drugs may lessen brain function, says ISU researcherMon, 23 Feb 2009, 17:37:02 EST
Other sources
- Bad cholesterol inhibits the breakdown of peripheral fatfrom PhysorgThu, 20 Nov 2008, 11:35:06 EST
- Bad cholesterol inhibits the breakdown of peripheral fatfrom Science CentricThu, 20 Nov 2008, 11:21:16 EST
- Bad Cholesterol Inhibits The Breakdown Of Peripheral Fatfrom Science DailyThu, 20 Nov 2008, 8:35:37 EST
Latest Science Newsletter
Get the latest and most popular science news articles of the week in your Inbox!Learn more about
Popular science news articles
- Scientists visualize how bacteria talk to one another
- Findings show nanomedicine promising for treating spinal cord injuries
- Deep creep means milder, more frequent earthquakes along Southern California's San Jacinto fault
- Developmental delay could stem from nicotinic receptor deletion
- Scientists uncover new key to the puzzle of hormone therapy and breast cancer
- African desert rift confirmed as new ocean in the making
- Why nice guys usually get the girls
- Does green tea prevent cancer? Evidence continues to brew, but questions remain
- Digital 'plaster' for monitoring vital signs undergoes first clinical trials
- Higher carotid arterial stenting rates associated with poorer clinical outcomes
- African desert rift confirmed as new ocean in the making
- 1 shot of gene therapy and children with congenital blindness can now see
- Scientists discover influenza's Achilles heel: Antioxidants
- Cleanliness is next to godliness: New research shows clean smells promote moral behavior
- Super typhoon Lupit heading west in the Philippine Sea
- African desert rift confirmed as new ocean in the making
- Common plants can eliminate indoor air pollutants
- Study reveals a 'missing link' in immune response to disease
- Reduction in glycotoxins from heat-processing of foods reduces risk of chronic disease
- Digital 'plaster' for monitoring vital signs undergoes first clinical trials